BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17414584)

  • 41. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
    Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
    Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ambulatory blood pressure measurement in assessing the antihypertensive effect of benazepril plus hydrochlorothiazide in a fixed combination.
    Valvo E; Bedogna V; Casagrande P
    Clin Ther; 1993; 15(4):650-6. PubMed ID: 8221814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
    Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
    Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
    Nashar K; Nguyen JP; Jesri A; Morrow JD; Egan BM
    Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characteristics of hypotensive effect in patients with arterial hypertension and desaturation signs of obstructive sleep apnea syndrome during sleep].
    Zelveian PA; Oshchepkova EV; Buniatian MS; Rogoza AN
    Ter Arkh; 2004; 76(6):81-4. PubMed ID: 15332583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melatonin reduces night blood pressure in patients with nocturnal hypertension.
    Grossman E; Laudon M; Yalcin R; Zengil H; Peleg E; Sharabi Y; Kamari Y; Shen-Orr Z; Zisapel N
    Am J Med; 2006 Oct; 119(10):898-902. PubMed ID: 17000226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
    Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
    J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension.
    Shiga Y; Miura S; Mitsutake R; Uehara Y; Inoue A; Saku K
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):107-12. PubMed ID: 21746766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension.
    Lacourcière Y; Poirier L
    Am J Hypertens; 2003 Dec; 16(12):1036-42. PubMed ID: 14643578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.
    Little WC; Zile MR; Klein A; Appleton CP; Kitzman DW; Wesley-Farrington DJ
    Am J Cardiol; 2006 Aug; 98(3):383-5. PubMed ID: 16860028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of combination therapy with losartan/hydrochlorothiazide on the relationships between base blood pressure, autonomic function, and health-related QOL].
    Okano Y; Toya Y; Azuma K; Yabana M; Tamura K; Umemura S
    Nihon Jinzo Gakkai Shi; 2010; 52(7):939-44. PubMed ID: 21077345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
    Donner KM; Hiltunen TP; Hannila-Handelberg T; Suonsyrjä T; Kontula K
    Hypertens Res; 2012 Jan; 35(1):107-14. PubMed ID: 21993215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).
    Tardif JC; Curnew GP; Leclerc JM; Rehel B
    Can J Clin Pharmacol; 2008; 15(2):e177-87. PubMed ID: 18515919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.
    Porthan K; Viitasalo M; Hiltunen TP; Vaananen H; Dabek J; Suonsyrja T; Hannila-Handelberg T; Virolainen J; Nieminen MS; Toivonen L; Kontula K; Oikarinen L
    Ann Med; 2009; 41(1):29-37. PubMed ID: 18608135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.